Safety and Efficacy of IMPT or IMRT for Breast Cancer

Clinical trial NCT06826885 · RECRUITING

Trial details

NCT number: NCT06826885
Sponsor: Ruijin Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Proton Therapy Intensity Modulated Radiation Therapy Efficacy and Safety Radiotherapy, Adjuvant

Start date: 2024-12-01
Primary completion: 2029-11-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.